查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1993815

医药中心和病患准入支援服务市场：全球产业分析、市场规模、市场份额及按服务交付方式、支付方、服务类型、适应症、国家和地区分類的预测（2025年至2032年）

Pharma Hub and Patient Access Support Service Market, By Service Delivery Type, By Payer Type, By Service Type, By Indication, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 353 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年，医药中心和病患准入支援服务的市场规模价值为 33.6787 亿美元，预计从 2025 年到 2032 年将以 7.58% 的复合年增长率成长。

医药中心和患者准入支援服务市场是一个专业的外包服务生态系统，旨在帮助製药公司简化患者入院流程、报销流程导航、治疗依从性管理以及后续支持，尤其针对专科药物和高价药物。报销框架和专科药物日益复杂化是推动成长要素，也促使製药商确保患者能更快获得治疗。人工智慧驱动的病人参与平台和数位化个案管理工具的整合是关键趋势。然而，严格的资料隐私法规和支付系统的碎片化构成了阻碍因素。同时，生物製药产品线的拓展和基于价值的医疗模式的兴起，为全球范围内先进的、以结果为导向的患者准入解决方案创造了巨大的机会。

医药中心和病人准入支援服务市场 - 市场动态

製药业的扩张正在推动医药中心和病患准入支援服务市场的成长。

预计对药品日益增长的需求将推动医药中心和患者准入支持服务市场的发展。随着药品生产、就业和研发投入的持续成长，进入市场的专科和高价疗法数量显着增加。这种扩张带动了对系统化病患入院流程、报销支援、治疗依从性计画和财务支援服务的需求。例如，代表欧洲研发製药业的比利时行业协会——欧洲製药商协会（EFPIA）报告称，预计到2025年，欧洲製药业产值将从2023年的约4381.6亿美元增至2024年的约4752亿美元，研发支出也将相应增长。此产业扩张将直接增加对综合性患者准入和中心支援服务的需求，从而确保及时启动治疗并改善患者预后。

医药枢纽和病患准入支援服务市场 - 市场細項分析：

全球医药中心和病患准入支援服务市场按服务交付模式、支付方类型、服务类型、适应症和地区进行细分。

预计到2026年，专案註册领域将占据市场的大部分份额。计画註册是指将患者登记到特定计画中，这些计画旨在为他们提供所需的医疗服务、药物或支持，以帮助他们管理自身健康。对客製化解决方案日益增长的需求以及改善患者治疗效果的愿望正在推动患者註册服务的需求。多家公司正在推出新的专案註册解决方案，这将有助于市场成长。例如，辉瑞公司于2022年12月发布了“辉瑞PAP印度版”，这是一款行动应用程序，旨在简化和加快其患者准入计划（PAP）的註册流程。辉瑞公司经营十多个项目，为接受治疗的患者提供支援。

预计到2026年，整合服务将主导市场。随着复杂药物的上市以及有效市场进入变得至关重要，製造商正在寻求综合方法来简化其服务。整合解决方案提供了一个统一的平台，用于管理患者准入、报销支援和药房协作等各种功能。为了应对产品生命週期的复杂性，领先的製造商正在扩展其服务范围。 Terebellum（AscellaHealth）计划于2023年3月扩展其面向生命科学製造商的HUB/患者支援服务。这些服务将有助于患者获得药物、提高药物依从性并改善治疗效果。 Terebellum的外包解决方案被广泛认为是业界最佳。

医药枢纽和病患准入支援服务市场—区域洞察

预计到2026年，欧洲医药中心和病患准入支援服务市场将占据相当大的收入份额。作为已开发地区，欧洲拥有较高的医疗保健支出能力，从而带动了对医药中心和病患准入支援服务需求的成长。此外，随着欧洲老年人口的增长，目标疾病的盛行率也预计将上升，进一步增加该地区对患者准入支援服务的需求。英国医药中心和病患准入支援服务市场预计在预测期内将显着成长。由于英国优先发展数位医疗并加大对研发创新的投入，医药中心和病患准入支援服务在推动临床研究和改善病患预后方面预计将发挥越来越重要的作用。

德国医药中心及病患准入支援服务市场—国家概况

2026年，德国的医药中心和病患准入支援服务市场在欧洲地区占据主导地位。在德国，以病人为中心的医疗保健和临床研究方法正日益受到重视。根据Cardinal Health在2022年发表的一篇报导，超过90%的医师表示，预先核准流程导致患者照护延误。由于情况复杂，约37%的医生放弃了申请。为了确保患者能够获得并继续接受治疗，需要诸如eBV和ePA等技术解决方案来缩短预先核准和电子福利申请的处理时间。

目录

第一章：医药中心和病人准入支援服务市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：医药中心和病人准入支援服务的关键市场趋势

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 未来市场趋势

第四章：医药中心和病人准入支持服务业的分析

  • PEST分析
  • 波特五力分析
  • 市场成长前景展望图
  • 管理体制分析

第五章：医药中心与病人进入支援服务市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：医药中心和病人准入支援服务的市场趋势

  • 2024年医药中心和病人准入支持服务市场份额分析
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 医药中心与病人进入支援服务市场：依服务提供方式划分

  • 概述
    • 细分市场占有率分析：依服务交付方式划分
    • 独立服务
    • 综合服务

第八章 医药中心与病人进入支援服务市场：依支付方类型划分

  • 概述
    • 细分市场占有率分析：依支付方类型划分
    • 联邦医疗保险
    • 私人保险
    • 自费
    • 公共保险
    • 医疗补助

第九章 医药中心及病人进入支援服务市场：依服务类型划分

  • 概述
    • 基于细分市场的市场占有率分析：按服务类型
    • 临床教育者
    • 治疗导航员
      • 业务流程和标准作业程式
      • 护理团队培训
      • 节目资料和剧本
      • 系统测试与最佳化
    • 专案註册
      • 註册便利性（可透过电话、亲自​​前往、入口网站或应用程式）
      • 订单处理
      • 应用程式处理
      • 程式数据
    • 报销服务/减轻经济负担服务
    • 在专业药房进行配药/分发
    • 其他的

第十章 医药中心与病人进入支持服务市场：依适应症划分

  • 概述
    • 细分市场占有率分析：依支付方类型划分
    • 肿瘤学
    • 呼吸系统疾病
    • 罕见疾病
    • 心血管疾病
    • 自体免疫疾病
    • 消化系统疾病

第十一章 医药中心和病人准入支援服务市场：按地区划分

  • 介绍
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 主要製造商：欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 概述
    • 主要製造商：亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他亚太国家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他拉丁美洲国家
  • 中东和非洲
    • 概述
    • 主要生产商：中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他中东和非洲国家

第十二章 主要供应商分析：医药中心与病患准入支援服务业

  • 竞争基准
    • 竞争对手仪錶板
    • 竞争定位
  • 公司简介
    • McKesson Corporation
    • Valeris（Formerly PharmaCord）
    • Cardinal Health
    • Envoy Health, Inc
    • EVERSANA
    • Fortrea
    • Mercalis
    • Sciensus
    • AssistRx
    • Lash Group
    • Engage
    • CareMetx, LLC
    • ConnectiveRx.
    • NS Pharma, Inc.（a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.）
    • United BioSource LLC
    • Others

第十三章：AnalystView 的全景视图

简介目录
Product Code: ANV6155

Pharma Hub and Patient Access Support Service Market size was valued at US$ 3,367.87 Million in 2024, expanding at a CAGR of 7.58% from 2025 to 2032.

The Pharma Hub and Patient Access Support Service Market is a specialized ecosystem of outsourced services that assists pharmaceutical companies in streamlining patient onboarding, reimbursement navigation, therapy adherence, and ongoing support, especially for specialty and high-cost drugs. The increasing complexity of reimbursement frameworks and specialty therapeutics is a major growth driver, putting pressure on manufacturers to ensure faster therapy access. The integration of AI-powered patient engagement platforms with digital case management tools is a key trend. However, stringent data privacy regulations and fragmented payer systems serve as constraints. At the same time, expanding biologics pipelines and value-based care models present significant opportunities for advanced, outcome-focused patient access solutions around the world.

Pharma Hub and Patient Access Support Service Market- Market Dynamics

Rising Pharmaceutical Industry Expansion Driving Growth in Pharma Hub and Patient Access Support Services Market

The growing demand for pharmaceutical products is expected to fuel growth in the Pharma Hub and Patient Access Support Service Market. As pharmaceutical production, employment, and R&D investments continue to rise, the number of specialty and high-cost therapies entering the market grows significantly. This expansion increases the demand for structured patient onboarding, reimbursement assistance, therapy adherence programs, and financial support services. For example, in 2025, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgian trade association that represents Europe's research-based pharmaceutical industry, reported that production in Europe increased from approximately $438.16 billion in 2023 to an estimated $475.2 billion in 2024, accompanied by increased R&D spending. Such industry expansion directly increases demand for comprehensive patient access and hub support services, which ensure timely therapy initiation and better patient outcomes.

Pharma Hub and Patient Access Support Service Market- Segmentation Analysis:

The Global Pharma Hub and Patient Access Support Service Market is segmented by Service Delivery Type, Payer Type, Service Type, Indication, and Region.

In 2026, the program enrollment segment will account for the majority of the share. Program enrollment is the process of registering patients in specific programs that aim to provide them with access to healthcare services, medications, or support needed to manage their health conditions. The growing demand for customized solutions, as well as the desire to improve patient outcomes, drives the demand for patient enrollment services. Several companies are launching new program enrollment solutions, which will help the market grow. For example, in December 2022, Pfizer Inc. launched 'Pfizer PAP India,' a mobile application that facilitates and expedites enrollment in Pfizer's Patient Access Programmes (PAP). Pfizer ran over ten programs to help patients undergoing treatments.

In 2026, integrated services will dominate the market. Manufacturers are seeking a comprehensive approach to streamline their services as complex pharmaceutical products are introduced and effective market access is required. Integrated solutions provide a unified platform for managing various functions such as patient access, reimbursement assistance, and pharmacy coordination. To deal with the complexities of the product lifecycle, key manufacturers are expanding their offerings. Terebellum (AscellaHealth) will expand its life sciences manufacturers' HUB/patient support services in March 2023. These services promote patient access to medication, compliance, and improved outcomes. Terebellum's outsourced solutions are widely regarded as best in class.

Pharma Hub and Patient Access Support Service Market- Geographical Insights

In 2026, the pharma HUB and patient access support service market in Europe accounts for a significant revenue share. As a developed region, Europe has greater healthcare spending power, increasing demand for pharma HUB and patient access support services. Furthermore, as Europe's geriatric population grows, the prevalence of target diseases is expected to rise, increasing demand for patient access support services in the region. The UK pharma HUB and patient access support service market is expected to expand significantly over the forecast period. As the UK prioritizes digital health and invests in research and innovation, pharma HUBs and patient access support services are expected to become increasingly important in advancing clinical research and improving patient outcomes.

Germany Pharma Hub and Patient Access Support Service Market- Country Insights

In 2026, the German pharma HUB and patient access support service market dominated the European region. The country is increasingly focusing on patient-centered approaches to healthcare and clinical research. According to a 2022 article published by Cardinal Health, the prior authorization process causes patient care delays for more than 90% of physicians. Due to the complexities of the situation, approximately 37% of these physicians have abandoned requests. To ensure that patients have access to and remain on therapies, technology solutions such as eBV and ePA must be used to reduce onboarding time for both prior authorizations and electronic benefit investigations.

Pharma Hub and Patient Access Support Service Market- Competitive Landscape:

The pharma hub and patient access support service market is highly competitive, driven by the need to improve patient outcomes, accelerate therapy access, and enhance patient engagement across complex treatment pathways. Key service providers differentiate through comprehensive support offerings such as reimbursement assistance, financial support programs, patient education platforms, and digital care coordination tools. Partnerships with pharmaceutical manufacturers, payers, and specialty pharmacies are crucial to expanding service reach and ensuring seamless care delivery. Companies also focus on leveraging data analytics and AI to optimize patient identification, adherence monitoring, and outcome tracking. Prominent players in this space include Patient Connect, Innomar Strategies, Accredo Health Group (Express Scripts), and McKesson Corporation, each leveraging broad healthcare networks and integrated support solutions to strengthen market positioning.

Recent Developments:

In March 2025, Valeris is one of the largest independent patient access solution providers in the biopharmaceutical industry, having been formed by the merger of PharmaCord and Mercalis. This merger brings together PharmaCord's expertise in patient services and Mercalis' comprehensive commercialization solutions to improve patient access, affordability, therapy adherence, and overall healthcare delivery. The new organization intends to streamline the commercialization process and improve outcomes for patients and life science companies worldwide.

In June 2023, Labcorp announced the spin-off of Fortrea. Fortrea is now an independent CRO providing patient access, Phase I-IV clinical trial management, and technology solutions to biotechnology and pharmaceutical companies worldwide. This strategic move is expected to improve the company's ability to meet customer needs, unlock shareholder value, and make targeted value-creating investments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • McKesson Corporation
  • Valeris (Formerly PharmaCord)
  • Cardinal Health
  • Envoy Health, Inc
  • EVERSANA
  • Fortrea
  • Mercalis
  • Sciensus
  • AssistRx
  • Lash Group
  • Engage
  • CareMetx, LLC
  • ConnectiveRx.
  • NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
  • United BioSource LLC
  • Others

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE DELIVERY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Standalone Services
  • Integrated Services

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY PAYER TYPE- MARKET ANALYSIS, 2019 - 2032

  • Medicare
  • Commercial Insurance
  • Self-Pay
  • Government Insurance
  • Medicaid

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Educator
  • Treatment Navigators
  • Process flows and standard operating procedures
  • Care team training
  • Program literature and scripts
  • Systems testing and optimization
  • Program Enrolment
  • Ease of enrollment (through phone, face, portal, or app)
  • Order processing
  • Application processing
  • Program data
  • Reimbursement Services/Affordability Services
  • Coordination of Specialty Pharmacy/Dispensing
  • Others

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Respiratory Diseases
  • Rare Diseases
  • Cardiovascular Diseases
  • Autoimmune Disorders
  • Gastrointestinal Diseases

GLOBAL PHARMA HUB AND PATIENT ACCESS SUPPORT SERVICE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharma Hub and Patient Access Support Service Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharma Hub and Patient Access Support Service Market Snippet by Service Delivery Type
    • 2.1.2. Pharma Hub and Patient Access Support Service Market Snippet by Payer Type
    • 2.1.3. Pharma Hub and Patient Access Support Service Market Snippet by Service Type
    • 2.1.4. Pharma Hub and Patient Access Support Service Market Snippet by Indication
    • 2.1.5. Pharma Hub and Patient Access Support Service Market Snippet by Country
    • 2.1.6. Pharma Hub and Patient Access Support Service Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharma Hub and Patient Access Support Service Key Market Trends

  • 3.1. Pharma Hub and Patient Access Support Service Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharma Hub and Patient Access Support Service Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharma Hub and Patient Access Support Service Market Opportunities
  • 3.4. Pharma Hub and Patient Access Support Service Market Future Trends

4. Pharma Hub and Patient Access Support Service Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharma Hub and Patient Access Support Service Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharma Hub and Patient Access Support Service Market Landscape

  • 6.1. Pharma Hub and Patient Access Support Service Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharma Hub and Patient Access Support Service Market - By Service Delivery Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service Delivery Type, 2024 & 2032 (%)
    • 7.1.2. Standalone Services
    • 7.1.3. Integrated Services

8. Pharma Hub and Patient Access Support Service Market - By Payer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Payer Type, 2024 & 2032 (%)
    • 8.1.2. Medicare
    • 8.1.3. Commercial Insurance
    • 8.1.4. Self-Pay
    • 8.1.5. Government Insurance
    • 8.1.6. Medicaid

9. Pharma Hub and Patient Access Support Service Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
    • 9.1.2. Clinical Educator
    • 9.1.3. Treatment Navigators
      • 9.1.3.1. Process flows and standard operating procedures
      • 9.1.3.2. Care team training
      • 9.1.3.3. Program literature and scripts
      • 9.1.3.4. Systems testing and optimization
    • 9.1.4. Program Enrolment
      • 9.1.4.1. Ease of enrollment (through phone, face, portal, or app)
      • 9.1.4.2. Order processing
      • 9.1.4.3. Application processing
      • 9.1.4.4. Program data
    • 9.1.5. Reimbursement Services/Affordability Services
    • 9.1.6. Coordination of Specialty Pharmacy/Dispensing
    • 9.1.7. Others

10. Pharma Hub and Patient Access Support Service Market - By Indication

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Payer Type, 2024 & 2032 (%)
    • 10.1.2. Oncology
    • 10.1.3. Respiratory Diseases
    • 10.1.4. Rare Diseases
    • 10.1.5. Cardiovascular Diseases
    • 10.1.6. Autoimmune Disorders
    • 10.1.7. Gastrointestinal Diseases

11. Pharma Hub and Patient Access Support Service Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pharma Hub and Patient Access Support Service Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Pharma Hub and Patient Access Support Service Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Service Delivery Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Payer Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pharma Hub and Patient Access Support Service Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. McKesson Corporation
    • 12.2.2. Valeris (Formerly PharmaCord)
    • 12.2.3. Cardinal Health
    • 12.2.4. Envoy Health, Inc
    • 12.2.5. EVERSANA
    • 12.2.6. Fortrea
    • 12.2.7. Mercalis
    • 12.2.8. Sciensus
    • 12.2.9. AssistRx
    • 12.2.10. Lash Group
    • 12.2.11. Engage
    • 12.2.12. CareMetx, LLC
    • 12.2.13. ConnectiveRx.
    • 12.2.14. NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
    • 12.2.15. United BioSource LLC
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us